SCHEMBL21035141

SCHEMBL21035141

CC(=O)CCC(C)(C)C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
LMNA P02545 4/20 0.38
SLC15A2 Q16348 1/20 0.38
PAOX Q6QHF9 2/20 0.37
GAA P10253 1/20 0.36
ALOX15 P16050 2/20 0.35
BLM P54132 2/20 0.35
PMP22 Q01453 2/20 0.35
ACHE P22303 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
POLB P06746 2/20 0.31
HSD17B10 Q99714 2/20 0.31
HMGCR P04035 1/20 0.31
CHRM1 P11229 1/20 0.31
TBXA2R P21731 1/20 0.31
ADRA1A P35348 1/20 0.31
TRPA1 O75762 1/20 0.30
KDM4E B2RXH2 1/20 0.30
GMNN O75496 1/20 0.30
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21034430 0.83 ALDH1A1 (0.39) ALDH1A1LMNASLC15A2PAOXGAA
SCHEMBL11918240 0.81 ALDH1A1 (0.47) ALDH1A1LMNASLC15A2PAOXGAA
SCHEMBL3293803 0.81 LMNA (0.38) ALDH1A1LMNAALOX15BLMPMP22
Hydrochloric Acid SCHEMBL6214815 0.79 LMNA (0.36) ALDH1A1LMNAALOX15BLMPMP22
SCHEMBL2612046 0.79 ALDH1A1 (0.45) ALDH1A1LMNASLC15A2GAATDP1
SCHEMBL27669499 0.79 ALDH1A1 (0.46) ALDH1A1LMNASLC15A2BLMPMP22
SCHEMBL23393881 0.77 LMNA (0.30) LMNAHSD17B10
SCHEMBL9842065 0.76 LMNA (0.37) ALDH1A1LMNAALOX15BLMPMP22
SCHEMBL23905225 0.75 TDP1 (0.32) ALDH1A1TDP1CYP1A2
SCHEMBL31016295 0.75 ALDH1A1 (0.41) ALDH1A1LMNASLC15A2PAOXGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2555769-B1 METHODS FOR TREATING RESPIRATORY VIRAL INFECTION AMGEN EUROPE GMBH (CH) 2022-01-12 EP disclosed
EP-3904875-A1 METHODS FOR DETERMINING DRUG EFFICACY USING IKZF3 (AIOLOS) Celgene Corporation (US) 2021-11-03 EP disclosed
EP-3489682-B1 METHODS FOR DETERMINING DRUG EFFICACY USING IKZF3 (AIOLOS) CELGENE CORP (US) 2021-03-31 EP disclosed
EP-3489682-A1 METHODS FOR DETERMINING DRUG EFFICACY USING IKZF3 (AIOLOS) Celgene Corporation (US) 2019-05-29 EP disclosed